Form 8-K - Current report:
SEC Accession No. 0000950103-24-003156
Filing Date
2024-02-29
Accepted
2024-02-29 16:30:37
Documents
17
Period of Report
2024-02-23
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K dp207290_8k.htm   iXBRL 8-K 23457
2 EXHIBIT 10.1 dp207290_ex1001.htm EX-10.1 37601
3 GRAPHIC image_002.jpg GRAPHIC 4254
4 GRAPHIC image_003.jpg GRAPHIC 4254
  Complete submission text file 0000950103-24-003156.txt   254237

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE adct-20240223.xsd EX-101.SCH 3036
6 XBRL LABEL FILE adct-20240223_lab.xml EX-101.LAB 34240
7 XBRL PRESENTATION FILE adct-20240223_pre.xml EX-101.PRE 22373
18 EXTRACTED XBRL INSTANCE DOCUMENT dp207290_8k_htm.xml XML 3696
Mailing Address BIOPOLE ROUTE DE LA CORNICHE 3B EPALINGES V8 1066
Business Address BIOPOLE ROUTE DE LA CORNICHE 3B EPALINGES V8 1066 41 21 653 02 00
ADC Therapeutics SA (Filer) CIK: 0001771910 (see all company filings)

EIN.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39071 | Film No.: 24704241
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)